Clinical microbiological case: facial inflammation in a child with a subnormal serum concentration of IgG2  by Paraskakis, I. et al.
ANSWERS TO CONTINUING MEDICAL EDUCATION QUESTIONS
Clinical microbiological case: facial
inflammation in a child with a subnormal
serum concentration of IgG2
I. Paraskakis, G. Stamos, C. S. Stavrinadis,
E. Lebessi, K. Kallergi, D. A. Kafetzis and
N. J. Legakis
Please refer to the article on pages xx–xx of this
issue to view the questions to which these answers
refer.
ANSWERS
1. The clinical diagnosis was facial cellulitis. Blood,
urine and perhaps tissue aspirates and biopsy
material in more aggressive soft tissue infections
shouldbeculturedbeforeempirical therapy is insti-
tuted in any case of suspected systemic disease
following cellulitis.
2. The most common etiologic agents of cellulitis
in normal hosts are Streptococcus pyogenes and Sta-
phylococcus aureus (usually associated with a skin
ulcer or abscess). In the case reported here, the
presumptive identiﬁcation of the organism was
suggestive of an unusual Gram-negative, oxidase-
positive pathogen.
3. Patients should receive antimicrobial therapy
effective against the most usual infective agents,
Streptococcus pyogenes and Staphylococcus aureus.
Therefore, cephalothin, cefuroxime, vancomycin
or erythromycin are acceptable choices. For ser-
ious infections, clindamycin is more potent, be-
cause of its ability to suppress the synthesis of
many streptococcal exotoxins and surface
proteins.
The identiﬁcation and sensitivity testing of
Gram-negative, oxidase-positive rods other than
Pseudomonas aeruginosa can sometimes be delayed
for a couple of days. On the second day of hospi-
talization, the patient’s clinical condition had
markedly improved. Therefore, high-dose intrave-
nous cefuroxime was considered to be effective,
being usually active against most community-
acquired Staphylococcus aureus isolates.
4. Gram-negative, oxidase-positive rods other
than Pseudomonas aeruginosa are frequently oppor-
tunistic pathogens. The ﬁnding of bacteremia
caused by such an organism in a previously
healthy individual led to the early decision to
investigate his immunologic status.
LABORATORY RESULTS AND
OUTCOME
Pseudomonas stutzeri was recovered from three
blood cultures and urine culture (>105/mL). The
ﬁnal identiﬁcation was made by the API 20NE
biotyping system (bioMerieux, Marcy l’Etoile,
France). Nasal cultures also yielded P. stutzeri,
in combination with Staphylococcus aureus. Sensi-
tivity testing of the organisms was performed by
a microtiter broth dilution method (ﬂuorogenic
substrate system, Sensititre; Trek Diagnostic Sys-
tems Ltd., West Sussex, UK). Staphylococcus aureus
was methicillin sensitive, indicating sensitivity to
cephalosporins as well. The P. stutzeri isolate was
found to be resistant to ampicillin, piperacillin,
cephalothin, gentamicin, netilmicin, tobramycin
and sulfamethoxazole–trimethoprim, intermedi-
ately sensitive to cefuroxime, and sensitive to
third-generation cephalosporins and quinolones.
It had the same biochemical proﬁle and the same
resistance phenotype in all cultures.
We thoroughly researched the patient’s history
to ﬁnd possible sources of the isolated microor-
ganisms in his environment. No contact with soil,
sewage, animals or other possible contamination
sources was reported, but there was information of
a well reconstruction in the child’s residence a few
days before the onset of symptoms.
On the fourth day of hospitalization, the intra-
venous cefuroxime administration was changed to
cefuroxime axetil administered orally (40mg/kg/
24 h) for 1 week. Erythrocyte sedimentation rate
(ESR) and C-reactive protein (CRP) levels were
restored to normal on the sixth day, and the child
was discharged in very good condition. Blood,
urine and nasal cultures taken on discharge did
not reveal P. stutzeri or any other pathogen.
At a follow-up visit 2 weeks after discharge, the
patient was found to be afebrile and pain-free, and
the skin lesion had completely resolved. After a 2-
year period, the child had no evidence of health
disorders.
DISCUSSION
P. stutzeri is found in soil, sewage, manure, straw
and water as a saprophyte, but has also been
isolated from aqueous hospital environments
and contaminated intravenous ﬂuids [1–5]. It
has been mostly found as a contaminant [1–3],
but it has been involved occasionally in human
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infections, such as wound infections, pneumonia,
bone and joint infections, eye infections, otitis
media and bacteremia [1,2,6–11]. Infections in
healthy children have been reported twice: a 7-
year-old-girl with otitis media, and a 12-year-old
boy with calcaneal osteomyelitis [6,7].
In the presented case, P. stutzeri involvement in
cellulitis was not clear. Staphylococcus aureus could
be the causative agent of the superﬁcial skin lesion,
which probably served as the portal of entry and
dissemination of P. stutzeri. The initial source of
bacterial contamination was not apparent, but the
dust from the reconstruction work in the patient’s
house could have played a role in transferring the
microorganisms.
Medical devices, trauma or serious underlying
diseases, especially in debilitated adults, have been
considered as predisposing factors for P. stutzeri
infections [1,2,6–11]. In this case, none of the above
factors was present, but the ﬁnding of IgG2 deﬁ-
ciency was noteworthy. This condition has been
associated with frequent polysaccharide-encapsu-
lated bacterial infections in children [12], but its
contribution to the Pseudomonas invasive infection
in this case could not be clearly demonstrated.
To our knowledge, we report the ﬁrst case of
P. stutzeri bacteremia following facial cellulitis.
The role of IgG2 deﬁciency in Pseudomonas spp.
infections needs further evaluation. A thorough
laboratory investigationofpredisposing factors, in-
cluding examination of the immunologic status of
the patients, is recommended in similar infections.
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